Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach

International Journal of Clinical Pharmacology and Therapeutics

Volumn 46, Issue 12, 2008, Pages 617-626

  ElDesoky, E S ^a   Kumar, V ^b   Alorainy, M S ^c   Hamdi, M M ^a   Derendorf, H ^b  

^a Assiut University Faculty of Medicine   (Egypt)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Adults; Bipolar; Lithium; PK PD modeling; Population clearance

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; CREATININE; HALOPERIDOL; LAMOTRIGINE; LITHIUM CARBONATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG WITHDRAWAL; EGYPT; FEMALE; HUMAN; MALE; POPULATION RESEARCH; UNSPECIFIED SIDE EFFECT;

EID: 57149142788     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP46617     Document Type: Article

References (35)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 1994 b. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry. 1994; 151: 1-136.
2. Baldessarini RJ, Tarazi FI. Pharmacotherapy of psychosis and mania. In: Brunton LL, Lazo JS, Parker KL (eds.) Goodman & Gilman's The Pharmacological basis of Therapeutics. 11th edition. USA: MacGraw-Hill; 2006. pp. 18-461-18-500.
3. Baldessarini RJ, Tondo L, Hennen J, Figuera AC. Is lithium still worth using? An update of selected recent research. Harv Rev Psychiatry. 2002; 10: 59-75.
4. Booth BP, Gobburu JV. Considerations in analyzing single-trough concentrations using mixed-effects modeling. J Clin Pharmacol. 2003; 43: 1307-1315.
5. Carson SW. Lithium. In: Evans WE, Schentag JJ, Jusko WJ (eds.) Applied pharmacokinetics: Principles of Therapeutic Drug Monitoring. 3rd ed. Vancouver: Applied Therapeutics; 1992. p. 34-1-34-26.
6. Cates ME, Sims PJ. Therapeutic drug management of lithium. American Journal of Pharmaceutical Education. 2005; 69: 1-5.
7. Chen KP, Shen WW, Lu ML. Implication of serum concentration monitoring in patients with lithium intoxication. Psychiatry Clin Neurosci. 2004; 58: 25-29.
8. Chiu CC, Shen WW, Chen KP, Lu ML. Application of the Cockcroft-Gault method to estimate lithium dosage requirement. Psychiatry Clin Neurosci. 2007; 61: 269-274.
9. Cockcroft DW, Gault MH. Prediction of cretinine. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
10. Dunner DL. Optimizing lithium treatment. J Clin Psychiatry 2000; 61 (Suppl 9): 76-81.
11. Eisendrath SJ, Lichtmacher JE. Psychiatric disorders. In: Tierney Jr LM, McPhee SJ, Papadakis MA (eds.) Current Medical Diagnosis & Treatmen. 45th edition. USA: McGraw-Hill; 2006. p. 1038-1097.
12. EL Desoky ES, Nagaraja NV, Derendorf H. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization. Am J Ther. 2002; 9: 492-498.
13. Eyer F, Pfab R, Felgenhauer N, Lutz J, Heemann U et al. Lithium poisoning: pharmacokinetics and clearance during different therapeutic measures. J Clin Psychopharmacol. 2006; 26: 324-330.
14. Groleau G. Lithium toxicity. Emergency medical clinics of North America. 1994; 511: 511-531.
15. Hallworth M, Capps N. Lithium. In: Therapeutic Drug Monitoring and Clinical Biochemistry. Chapter 2: Individual drugs. London: ACB Ventrure; 1993. p. 65-69.
16. Kleindienst N, Severus WE, Greil W. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. Int Clin Psychopharmacol. 2007; 22: 125-131.
17. Lee CF, Yang YY, Hu OY. Single dose pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients. Aust N Z J Psychiatry. 1998; 32:133-136.
18. Maj M. The effect of lithium in bipolar disorder: a review of recent research evidence. Bipolar Disorders. 2003; 5: 180-188.
19. Parke J, Holford NH, Charles BG. A procedure for generating bootstrap samples for the validation of nonlinear mixed effects population models. Comput Methods Programs Biomed. 1999; 59: 19-29.
20. Simhandl C, Mersch J. Lithium and bipolar disorder - a renaissance? Neuropsychiatr. 2007; 21: 121-130.
21. Sproule B. Lithium in bipolar disorder. Can drug concentrations predict therapeutic effect? Clin Pharmacokinet. 2002; 41: 639-660.
22. Strickland TL, Lin KM, Fu P, Anderson D, Zheng Y. Comparison of lithium ratio between African-American and Caucasian bipolar patients. Biol Psychiatry. 1995; 37: 325-330.
23. Sun H, Fadiran EO, Jones CD, Lesko L, Huang SM et al. Population pharmacokinetics: a regulatory perspective. Clin Pharmacokinet. 1999; 37: 41-58.
24. Suppes T Dennehy EB, Hirschfeld RM, Altshuler LL, Bowden CL et al. The Texas implementation of medication algorithms: Update to the algoriths for treatment of bipolar I disorders. J Clin Psychiatry. 2005; 66: 870-886.
25. Taright N, Mentre F, Mallet A, Jouvent R. Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: Individualization of chronic dosing regimen using a new Bayesian approach. Ther Drug Monit 1994; 16: 258-269.
26. Thomsen K, Schou M. Avoidance of lithium intoxication: advice based on knowledge about the renal lithium clearance under various circumstances. Pharmacopsychiatry 1999; 32: 83-86.
27. US FDA Guidance for Industry: Population Pharmacokinetics; http://www.fda.gov/CDER/guidance/1852fnl.pdf.
28. Valecha N, Tayal G, Tripathi KD. Single dose pharmacokinetics of lithium & prediction of maintenance dose in manic depressive patients. Indian J Med Res. 1990; 92: 409-416.
29. Vertrees JE, Ereshefshy L. Lithium. In: Schumacher GE (ed.) Therapeutic Drug Monitoring. Noewalk: Appleton & Langer. 1995; p. 493-526.
30. Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol. 1994; 34: 280-285.
31. Webb AL, Solomon DA, Ryan CE. Lithium levels and toxicity among hospitalized patients. Psychiatric Services 2001; 52: 229-231.
32. Wing YK, Chan E, Chan K, Lee S, Shek CC. Lithium pharmacokinetics in Chinese manic-depressive patients. J Clin Psychopharmacol. 1997; 17: 179-184.
33. Yang YY, Yeh EK, Chang SS, Deng HC, Lee CF. Maintenance lithium levels could be lowered: based on Taiwanese and Danish studies. J Formos Med Assoc. 1991; 90: 509-513.
34. Yukawa E. Population-based investigations of drug relative clearance using nonlinear mixed-effect modeling from information generated during the routine clinical care of patients. J Clin Pharm Ther. 1999; 24: 103-113.
35. Yukawa E, Nomiyama N, Higuchi S, Aoyama T. Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. Ther Drug Monit. 1993; 15: 75-82.